Revivol Hemorrhoid and Fissure

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Revivol Hemorrhoid and Fissure
Generic name: GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25%
Manufacturer: Derma Care Research Labs, LLC
Product type: HUMAN OTC DRUG
SPL set ID: 0140cf68-b6a0-4378-e063-6394a90afee8
SPL ID: 29a5d178-edca-5e44-e063-6394a90aa6a9
Version: 2
Effective date: 2024-12-19
Source export date: 2026-10-27
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/a758d73d4d838a965005e6adf01b928e2da86f99be0f8bbaeeb95f3b7acbe418/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 19:58:47

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 14 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M015	openfda.application_number
brand name		Revivol Hemorrhoid and Fissure	openfda.brand_name
generic name		GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25%	openfda.generic_name
manufacturer name		Derma Care Research Labs, LLC	openfda.manufacturer_name
ndc	package	72839-295-01	openfda.package_ndc
ndc	product	72839-295	openfda.product_ndc
ndc11	package	72839029501	derived:openfda.package_ndc
rxcui		2642220	openfda.rxcui
spl id		29a5d178-edca-5e44-e063-6394a90aa6a9	id
spl set id		0140cf68-b6a0-4378-e063-6394a90afee8	set_id
unii		4T6H12BN9U	openfda.unii
unii		98PI200987	openfda.unii
unii		PDC6A3C0OX	openfda.unii
unii		04JA59TNSJ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external and/or intrarectal use. Ask a doctor before use if you have: heart disease, high blood pressure, thyroid disease, diabetes, or difficulty in urination due to enlargement of the prostate gland. Ask a doctor or pharmacist before use if you are presently taking a prescription drug for high blood pressure or depression. When using this product do not exceed recommended dosage unless directed by a doctor. Stop use and ask a doctor if condition worsens or does not improve within seven (7) days, bleeding occurs, an allergic reaction develops, the symptom being treated does not subside or if redness, irritation, swelling, pain or other symptoms develop or increase.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.